Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOFlipid 20% versus Intralipid 20% for postoperative parenteral nutrition after moderate or major abdominal surgery
ChiCTR-TRC-08000230Phase 3Recruiting
- Sponsor
- Jinling Hospital
- Start
- May 2008
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of SMOFlipid and Intralipid 10% in None (2 arms), sponsored by Jinling Hospital. Primary endpoints: Serum triglycerides, Prealbumin and 1 more. Started May 2008; status: recruiting.
02
Drugs
SMOFlipidIntralipid 10%
Beyond the preview
Go deeper on ChiCTR-TRC-08000230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000230.